nodes	percent_of_prediction	percent_of_DWPC	metapath
Aciclovir—Nucleoside Analog—Azathioprine—systemic scleroderma	0.806	1	CiPCiCtD
Aciclovir—SLC22A6—Captopril—systemic scleroderma	0.0396	0.565	CbGbCtD
Aciclovir—SLC22A8—Methotrexate—systemic scleroderma	0.018	0.256	CbGbCtD
Aciclovir—SLC22A6—Methotrexate—systemic scleroderma	0.0125	0.178	CbGbCtD
Aciclovir—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000109	0.000879	CcSEcCtD
Aciclovir—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000109	0.000877	CcSEcCtD
Aciclovir—Somnolence—Mycophenolic acid—systemic scleroderma	0.000108	0.000874	CcSEcCtD
Aciclovir—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000874	CcSEcCtD
Aciclovir—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000869	CcSEcCtD
Aciclovir—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000108	0.000867	CcSEcCtD
Aciclovir—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000107	0.000866	CcSEcCtD
Aciclovir—Neutropenia—Prednisone—systemic scleroderma	0.000107	0.000865	CcSEcCtD
Aciclovir—Tachycardia—Lisinopril—systemic scleroderma	0.000107	0.000865	CcSEcCtD
Aciclovir—Body temperature increased—Azathioprine—systemic scleroderma	0.000107	0.000863	CcSEcCtD
Aciclovir—Abdominal pain—Azathioprine—systemic scleroderma	0.000107	0.000863	CcSEcCtD
Aciclovir—Skin disorder—Lisinopril—systemic scleroderma	0.000107	0.00086	CcSEcCtD
Aciclovir—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000106	0.000858	CcSEcCtD
Aciclovir—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000106	0.000856	CcSEcCtD
Aciclovir—Diarrhoea—Captopril—systemic scleroderma	0.000106	0.000856	CcSEcCtD
Aciclovir—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000106	0.000855	CcSEcCtD
Aciclovir—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000106	0.000854	CcSEcCtD
Aciclovir—Irritability—Methotrexate—systemic scleroderma	0.000106	0.000854	CcSEcCtD
Aciclovir—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000106	0.000851	CcSEcCtD
Aciclovir—Feeling abnormal—Leflunomide—systemic scleroderma	0.000105	0.00085	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000105	0.000849	CcSEcCtD
Aciclovir—Fatigue—Mycophenolic acid—systemic scleroderma	0.000105	0.000848	CcSEcCtD
Aciclovir—Nausea—Mometasone—systemic scleroderma	0.000105	0.000846	CcSEcCtD
Aciclovir—Anorexia—Lisinopril—systemic scleroderma	0.000105	0.000844	CcSEcCtD
Aciclovir—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000105	0.000843	CcSEcCtD
Aciclovir—Ataxia—Methotrexate—systemic scleroderma	0.000104	0.000841	CcSEcCtD
Aciclovir—Constipation—Mycophenolic acid—systemic scleroderma	0.000104	0.000841	CcSEcCtD
Aciclovir—Pain—Mycophenolic acid—systemic scleroderma	0.000104	0.000841	CcSEcCtD
Aciclovir—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000104	0.00084	CcSEcCtD
Aciclovir—Hypotension—Lisinopril—systemic scleroderma	0.000103	0.000828	CcSEcCtD
Aciclovir—Dizziness—Captopril—systemic scleroderma	0.000103	0.000827	CcSEcCtD
Aciclovir—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000102	0.000826	CcSEcCtD
Aciclovir—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000102	0.000824	CcSEcCtD
Aciclovir—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000102	0.000821	CcSEcCtD
Aciclovir—Urticaria—Leflunomide—systemic scleroderma	0.000102	0.000819	CcSEcCtD
Aciclovir—Abdominal pain—Leflunomide—systemic scleroderma	0.000101	0.000815	CcSEcCtD
Aciclovir—Body temperature increased—Leflunomide—systemic scleroderma	0.000101	0.000815	CcSEcCtD
Aciclovir—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000101	0.00081	CcSEcCtD
Aciclovir—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.0001	0.00081	CcSEcCtD
Aciclovir—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.0001	0.00081	CcSEcCtD
Aciclovir—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.0001	0.00081	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.0001	0.000807	CcSEcCtD
Aciclovir—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	9.99e-05	0.000806	CcSEcCtD
Aciclovir—Hypersensitivity—Azathioprine—systemic scleroderma	9.97e-05	0.000804	CcSEcCtD
Aciclovir—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	9.97e-05	0.000804	CcSEcCtD
Aciclovir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	9.97e-05	0.000804	CcSEcCtD
Aciclovir—Insomnia—Lisinopril—systemic scleroderma	9.94e-05	0.000801	CcSEcCtD
Aciclovir—Discomfort—Mycophenolate mofetil—systemic scleroderma	9.92e-05	0.0008	CcSEcCtD
Aciclovir—Paraesthesia—Lisinopril—systemic scleroderma	9.86e-05	0.000795	CcSEcCtD
Aciclovir—Vomiting—Captopril—systemic scleroderma	9.86e-05	0.000795	CcSEcCtD
Aciclovir—Dyspnoea—Lisinopril—systemic scleroderma	9.79e-05	0.00079	CcSEcCtD
Aciclovir—Rash—Captopril—systemic scleroderma	9.78e-05	0.000789	CcSEcCtD
Aciclovir—Dermatitis—Captopril—systemic scleroderma	9.77e-05	0.000788	CcSEcCtD
Aciclovir—Somnolence—Lisinopril—systemic scleroderma	9.77e-05	0.000788	CcSEcCtD
Aciclovir—Headache—Captopril—systemic scleroderma	9.72e-05	0.000784	CcSEcCtD
Aciclovir—Confusional state—Mycophenolate mofetil—systemic scleroderma	9.71e-05	0.000783	CcSEcCtD
Aciclovir—Dyspepsia—Lisinopril—systemic scleroderma	9.67e-05	0.00078	CcSEcCtD
Aciclovir—Body temperature increased—Mycophenolic acid—systemic scleroderma	9.64e-05	0.000777	CcSEcCtD
Aciclovir—Abdominal pain—Mycophenolic acid—systemic scleroderma	9.64e-05	0.000777	CcSEcCtD
Aciclovir—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	9.63e-05	0.000776	CcSEcCtD
Aciclovir—Oedema—Mycophenolate mofetil—systemic scleroderma	9.63e-05	0.000776	CcSEcCtD
Aciclovir—Decreased appetite—Lisinopril—systemic scleroderma	9.55e-05	0.00077	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Lisinopril—systemic scleroderma	9.48e-05	0.000765	CcSEcCtD
Aciclovir—Fatigue—Lisinopril—systemic scleroderma	9.47e-05	0.000764	CcSEcCtD
Aciclovir—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	9.44e-05	0.000761	CcSEcCtD
Aciclovir—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	9.42e-05	0.00076	CcSEcCtD
Aciclovir—Hypersensitivity—Leflunomide—systemic scleroderma	9.42e-05	0.00076	CcSEcCtD
Aciclovir—Pain—Lisinopril—systemic scleroderma	9.39e-05	0.000758	CcSEcCtD
Aciclovir—Constipation—Lisinopril—systemic scleroderma	9.39e-05	0.000758	CcSEcCtD
Aciclovir—Tachycardia—Mycophenolate mofetil—systemic scleroderma	9.39e-05	0.000758	CcSEcCtD
Aciclovir—Skin disorder—Mycophenolate mofetil—systemic scleroderma	9.35e-05	0.000754	CcSEcCtD
Aciclovir—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	9.31e-05	0.00075	CcSEcCtD
Aciclovir—Diarrhoea—Azathioprine—systemic scleroderma	9.26e-05	0.000747	CcSEcCtD
Aciclovir—Nausea—Captopril—systemic scleroderma	9.21e-05	0.000743	CcSEcCtD
Aciclovir—Abdominal discomfort—Methotrexate—systemic scleroderma	9.19e-05	0.000741	CcSEcCtD
Aciclovir—Anorexia—Mycophenolate mofetil—systemic scleroderma	9.18e-05	0.00074	CcSEcCtD
Aciclovir—Asthenia—Leflunomide—systemic scleroderma	9.17e-05	0.00074	CcSEcCtD
Aciclovir—Hallucination—Prednisone—systemic scleroderma	9.14e-05	0.000737	CcSEcCtD
Aciclovir—Feeling abnormal—Lisinopril—systemic scleroderma	9.05e-05	0.00073	CcSEcCtD
Aciclovir—Pruritus—Leflunomide—systemic scleroderma	9.05e-05	0.000729	CcSEcCtD
Aciclovir—Hypotension—Mycophenolate mofetil—systemic scleroderma	8.99e-05	0.000725	CcSEcCtD
Aciclovir—Gastrointestinal pain—Lisinopril—systemic scleroderma	8.98e-05	0.000724	CcSEcCtD
Aciclovir—Neutropenia—Methotrexate—systemic scleroderma	8.97e-05	0.000723	CcSEcCtD
Aciclovir—Dizziness—Azathioprine—systemic scleroderma	8.95e-05	0.000722	CcSEcCtD
Aciclovir—Upper respiratory tract infection—Methotrexate—systemic scleroderma	8.91e-05	0.000719	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	8.77e-05	0.000707	CcSEcCtD
Aciclovir—Photosensitivity reaction—Methotrexate—systemic scleroderma	8.75e-05	0.000706	CcSEcCtD
Aciclovir—Asthenia—Mycophenolic acid—systemic scleroderma	8.75e-05	0.000706	CcSEcCtD
Aciclovir—Diarrhoea—Leflunomide—systemic scleroderma	8.75e-05	0.000705	CcSEcCtD
Aciclovir—Urticaria—Lisinopril—systemic scleroderma	8.73e-05	0.000704	CcSEcCtD
Aciclovir—Insomnia—Mycophenolate mofetil—systemic scleroderma	8.71e-05	0.000702	CcSEcCtD
Aciclovir—Abdominal pain—Lisinopril—systemic scleroderma	8.68e-05	0.0007	CcSEcCtD
Aciclovir—Body temperature increased—Lisinopril—systemic scleroderma	8.68e-05	0.0007	CcSEcCtD
Aciclovir—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	8.64e-05	0.000697	CcSEcCtD
Aciclovir—Pruritus—Mycophenolic acid—systemic scleroderma	8.63e-05	0.000696	CcSEcCtD
Aciclovir—Vomiting—Azathioprine—systemic scleroderma	8.61e-05	0.000694	CcSEcCtD
Aciclovir—Eye disorder—Prednisone—systemic scleroderma	8.58e-05	0.000692	CcSEcCtD
Aciclovir—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	8.58e-05	0.000692	CcSEcCtD
Aciclovir—Somnolence—Mycophenolate mofetil—systemic scleroderma	8.56e-05	0.00069	CcSEcCtD
Aciclovir—Rash—Azathioprine—systemic scleroderma	8.54e-05	0.000688	CcSEcCtD
Aciclovir—Dermatitis—Azathioprine—systemic scleroderma	8.53e-05	0.000688	CcSEcCtD
Aciclovir—Headache—Azathioprine—systemic scleroderma	8.48e-05	0.000684	CcSEcCtD
Aciclovir—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	8.48e-05	0.000684	CcSEcCtD
Aciclovir—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	8.47e-05	0.000683	CcSEcCtD
Aciclovir—Dizziness—Leflunomide—systemic scleroderma	8.45e-05	0.000682	CcSEcCtD
Aciclovir—Renal failure—Methotrexate—systemic scleroderma	8.4e-05	0.000678	CcSEcCtD
Aciclovir—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	8.37e-05	0.000675	CcSEcCtD
Aciclovir—Diarrhoea—Mycophenolic acid—systemic scleroderma	8.35e-05	0.000673	CcSEcCtD
Aciclovir—Conjunctivitis—Methotrexate—systemic scleroderma	8.31e-05	0.00067	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	8.31e-05	0.00067	CcSEcCtD
Aciclovir—Immune system disorder—Prednisone—systemic scleroderma	8.3e-05	0.000669	CcSEcCtD
Aciclovir—Pain—Mycophenolate mofetil—systemic scleroderma	8.23e-05	0.000664	CcSEcCtD
Aciclovir—Constipation—Mycophenolate mofetil—systemic scleroderma	8.23e-05	0.000664	CcSEcCtD
Aciclovir—Haematuria—Methotrexate—systemic scleroderma	8.15e-05	0.000657	CcSEcCtD
Aciclovir—Vomiting—Leflunomide—systemic scleroderma	8.13e-05	0.000655	CcSEcCtD
Aciclovir—Alopecia—Prednisone—systemic scleroderma	8.12e-05	0.000654	CcSEcCtD
Aciclovir—Hypersensitivity—Lisinopril—systemic scleroderma	8.09e-05	0.000653	CcSEcCtD
Aciclovir—Hepatobiliary disease—Methotrexate—systemic scleroderma	8.09e-05	0.000652	CcSEcCtD
Aciclovir—Dizziness—Mycophenolic acid—systemic scleroderma	8.07e-05	0.00065	CcSEcCtD
Aciclovir—Rash—Leflunomide—systemic scleroderma	8.06e-05	0.00065	CcSEcCtD
Aciclovir—Dermatitis—Leflunomide—systemic scleroderma	8.05e-05	0.000649	CcSEcCtD
Aciclovir—Nausea—Azathioprine—systemic scleroderma	8.04e-05	0.000648	CcSEcCtD
Aciclovir—Headache—Leflunomide—systemic scleroderma	8.01e-05	0.000646	CcSEcCtD
Aciclovir—Erythema—Prednisone—systemic scleroderma	7.99e-05	0.000645	CcSEcCtD
Aciclovir—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	7.93e-05	0.00064	CcSEcCtD
Aciclovir—Asthenia—Lisinopril—systemic scleroderma	7.88e-05	0.000636	CcSEcCtD
Aciclovir—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	7.87e-05	0.000635	CcSEcCtD
Aciclovir—Pruritus—Lisinopril—systemic scleroderma	7.77e-05	0.000627	CcSEcCtD
Aciclovir—Vomiting—Mycophenolic acid—systemic scleroderma	7.75e-05	0.000625	CcSEcCtD
Aciclovir—Rash—Mycophenolic acid—systemic scleroderma	7.69e-05	0.00062	CcSEcCtD
Aciclovir—Dermatitis—Mycophenolic acid—systemic scleroderma	7.68e-05	0.00062	CcSEcCtD
Aciclovir—Hepatitis—Methotrexate—systemic scleroderma	7.68e-05	0.000619	CcSEcCtD
Aciclovir—Urticaria—Mycophenolate mofetil—systemic scleroderma	7.65e-05	0.000617	CcSEcCtD
Aciclovir—Headache—Mycophenolic acid—systemic scleroderma	7.64e-05	0.000616	CcSEcCtD
Aciclovir—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	7.61e-05	0.000614	CcSEcCtD
Aciclovir—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	7.61e-05	0.000614	CcSEcCtD
Aciclovir—Nausea—Leflunomide—systemic scleroderma	7.59e-05	0.000612	CcSEcCtD
Aciclovir—Urinary tract disorder—Methotrexate—systemic scleroderma	7.58e-05	0.000611	CcSEcCtD
Aciclovir—Urethral disorder—Methotrexate—systemic scleroderma	7.52e-05	0.000607	CcSEcCtD
Aciclovir—Diarrhoea—Lisinopril—systemic scleroderma	7.52e-05	0.000606	CcSEcCtD
Aciclovir—Ill-defined disorder—Prednisone—systemic scleroderma	7.42e-05	0.000598	CcSEcCtD
Aciclovir—Anaemia—Prednisone—systemic scleroderma	7.39e-05	0.000596	CcSEcCtD
Aciclovir—Agitation—Prednisone—systemic scleroderma	7.35e-05	0.000592	CcSEcCtD
Aciclovir—Angioedema—Prednisone—systemic scleroderma	7.3e-05	0.000589	CcSEcCtD
Aciclovir—Dizziness—Lisinopril—systemic scleroderma	7.26e-05	0.000586	CcSEcCtD
Aciclovir—Erythema multiforme—Methotrexate—systemic scleroderma	7.26e-05	0.000585	CcSEcCtD
Aciclovir—Nausea—Mycophenolic acid—systemic scleroderma	7.24e-05	0.000584	CcSEcCtD
Aciclovir—Malaise—Prednisone—systemic scleroderma	7.21e-05	0.000581	CcSEcCtD
Aciclovir—Vertigo—Prednisone—systemic scleroderma	7.18e-05	0.000579	CcSEcCtD
Aciclovir—Eye disorder—Methotrexate—systemic scleroderma	7.17e-05	0.000578	CcSEcCtD
Aciclovir—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	7.09e-05	0.000572	CcSEcCtD
Aciclovir—Vomiting—Lisinopril—systemic scleroderma	6.98e-05	0.000563	CcSEcCtD
Aciclovir—Immune system disorder—Methotrexate—systemic scleroderma	6.93e-05	0.000559	CcSEcCtD
Aciclovir—Rash—Lisinopril—systemic scleroderma	6.93e-05	0.000559	CcSEcCtD
Aciclovir—Convulsion—Prednisone—systemic scleroderma	6.93e-05	0.000559	CcSEcCtD
Aciclovir—Dermatitis—Lisinopril—systemic scleroderma	6.92e-05	0.000558	CcSEcCtD
Aciclovir—Mediastinal disorder—Methotrexate—systemic scleroderma	6.92e-05	0.000558	CcSEcCtD
Aciclovir—Asthenia—Mycophenolate mofetil—systemic scleroderma	6.91e-05	0.000557	CcSEcCtD
Aciclovir—Hypertension—Prednisone—systemic scleroderma	6.9e-05	0.000557	CcSEcCtD
Aciclovir—Chills—Methotrexate—systemic scleroderma	6.89e-05	0.000555	CcSEcCtD
Aciclovir—Headache—Lisinopril—systemic scleroderma	6.88e-05	0.000555	CcSEcCtD
Aciclovir—Pruritus—Mycophenolate mofetil—systemic scleroderma	6.81e-05	0.000549	CcSEcCtD
Aciclovir—Arthralgia—Prednisone—systemic scleroderma	6.81e-05	0.000549	CcSEcCtD
Aciclovir—Myalgia—Prednisone—systemic scleroderma	6.81e-05	0.000549	CcSEcCtD
Aciclovir—Alopecia—Methotrexate—systemic scleroderma	6.78e-05	0.000547	CcSEcCtD
Aciclovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	6.76e-05	0.000545	CcSEcCtD
Aciclovir—Discomfort—Prednisone—systemic scleroderma	6.72e-05	0.000542	CcSEcCtD
Aciclovir—Erythema—Methotrexate—systemic scleroderma	6.68e-05	0.000539	CcSEcCtD
Aciclovir—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	6.59e-05	0.000531	CcSEcCtD
Aciclovir—Dysgeusia—Methotrexate—systemic scleroderma	6.54e-05	0.000528	CcSEcCtD
Aciclovir—Nausea—Lisinopril—systemic scleroderma	6.53e-05	0.000526	CcSEcCtD
Aciclovir—Oedema—Prednisone—systemic scleroderma	6.52e-05	0.000526	CcSEcCtD
Aciclovir—Anaphylactic shock—Prednisone—systemic scleroderma	6.52e-05	0.000526	CcSEcCtD
Aciclovir—Nervous system disorder—Prednisone—systemic scleroderma	6.4e-05	0.000516	CcSEcCtD
Aciclovir—Tachycardia—Prednisone—systemic scleroderma	6.37e-05	0.000513	CcSEcCtD
Aciclovir—Dizziness—Mycophenolate mofetil—systemic scleroderma	6.37e-05	0.000513	CcSEcCtD
Aciclovir—Skin disorder—Prednisone—systemic scleroderma	6.34e-05	0.000511	CcSEcCtD
Aciclovir—Hyperhidrosis—Prednisone—systemic scleroderma	6.31e-05	0.000509	CcSEcCtD
Aciclovir—Anorexia—Prednisone—systemic scleroderma	6.22e-05	0.000502	CcSEcCtD
Aciclovir—Ill-defined disorder—Methotrexate—systemic scleroderma	6.2e-05	0.0005	CcSEcCtD
Aciclovir—Anaemia—Methotrexate—systemic scleroderma	6.18e-05	0.000498	CcSEcCtD
Aciclovir—Vomiting—Mycophenolate mofetil—systemic scleroderma	6.12e-05	0.000494	CcSEcCtD
Aciclovir—Rash—Mycophenolate mofetil—systemic scleroderma	6.07e-05	0.000489	CcSEcCtD
Aciclovir—Dermatitis—Mycophenolate mofetil—systemic scleroderma	6.06e-05	0.000489	CcSEcCtD
Aciclovir—Headache—Mycophenolate mofetil—systemic scleroderma	6.03e-05	0.000486	CcSEcCtD
Aciclovir—Malaise—Methotrexate—systemic scleroderma	6.03e-05	0.000486	CcSEcCtD
Aciclovir—Vertigo—Methotrexate—systemic scleroderma	6e-05	0.000484	CcSEcCtD
Aciclovir—Leukopenia—Methotrexate—systemic scleroderma	5.98e-05	0.000482	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Prednisone—systemic scleroderma	5.94e-05	0.000479	CcSEcCtD
Aciclovir—Insomnia—Prednisone—systemic scleroderma	5.9e-05	0.000476	CcSEcCtD
Aciclovir—Paraesthesia—Prednisone—systemic scleroderma	5.86e-05	0.000472	CcSEcCtD
Aciclovir—Convulsion—Methotrexate—systemic scleroderma	5.79e-05	0.000467	CcSEcCtD
Aciclovir—Dyspepsia—Prednisone—systemic scleroderma	5.74e-05	0.000463	CcSEcCtD
Aciclovir—Nausea—Mycophenolate mofetil—systemic scleroderma	5.72e-05	0.000461	CcSEcCtD
Aciclovir—Arthralgia—Methotrexate—systemic scleroderma	5.69e-05	0.000459	CcSEcCtD
Aciclovir—Chest pain—Methotrexate—systemic scleroderma	5.69e-05	0.000459	CcSEcCtD
Aciclovir—Myalgia—Methotrexate—systemic scleroderma	5.69e-05	0.000459	CcSEcCtD
Aciclovir—Decreased appetite—Prednisone—systemic scleroderma	5.67e-05	0.000457	CcSEcCtD
Aciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	5.65e-05	0.000456	CcSEcCtD
Aciclovir—Fatigue—Prednisone—systemic scleroderma	5.63e-05	0.000454	CcSEcCtD
Aciclovir—Discomfort—Methotrexate—systemic scleroderma	5.62e-05	0.000453	CcSEcCtD
Aciclovir—Constipation—Prednisone—systemic scleroderma	5.58e-05	0.00045	CcSEcCtD
Aciclovir—Confusional state—Methotrexate—systemic scleroderma	5.5e-05	0.000443	CcSEcCtD
Aciclovir—Anaphylactic shock—Methotrexate—systemic scleroderma	5.45e-05	0.00044	CcSEcCtD
Aciclovir—Feeling abnormal—Prednisone—systemic scleroderma	5.38e-05	0.000434	CcSEcCtD
Aciclovir—Nervous system disorder—Methotrexate—systemic scleroderma	5.35e-05	0.000431	CcSEcCtD
Aciclovir—Thrombocytopenia—Methotrexate—systemic scleroderma	5.34e-05	0.000431	CcSEcCtD
Aciclovir—Gastrointestinal pain—Prednisone—systemic scleroderma	5.34e-05	0.00043	CcSEcCtD
Aciclovir—Skin disorder—Methotrexate—systemic scleroderma	5.3e-05	0.000427	CcSEcCtD
Aciclovir—Hyperhidrosis—Methotrexate—systemic scleroderma	5.27e-05	0.000425	CcSEcCtD
Aciclovir—Anorexia—Methotrexate—systemic scleroderma	5.2e-05	0.000419	CcSEcCtD
Aciclovir—Urticaria—Prednisone—systemic scleroderma	5.18e-05	0.000418	CcSEcCtD
Aciclovir—Body temperature increased—Prednisone—systemic scleroderma	5.16e-05	0.000416	CcSEcCtD
Aciclovir—Abdominal pain—Prednisone—systemic scleroderma	5.16e-05	0.000416	CcSEcCtD
Aciclovir—Hypotension—Methotrexate—systemic scleroderma	5.1e-05	0.000411	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	4.97e-05	0.000401	CcSEcCtD
Aciclovir—Insomnia—Methotrexate—systemic scleroderma	4.93e-05	0.000398	CcSEcCtD
Aciclovir—Paraesthesia—Methotrexate—systemic scleroderma	4.9e-05	0.000395	CcSEcCtD
Aciclovir—Dyspnoea—Methotrexate—systemic scleroderma	4.86e-05	0.000392	CcSEcCtD
Aciclovir—Somnolence—Methotrexate—systemic scleroderma	4.85e-05	0.000391	CcSEcCtD
Aciclovir—Hypersensitivity—Prednisone—systemic scleroderma	4.81e-05	0.000388	CcSEcCtD
Aciclovir—Dyspepsia—Methotrexate—systemic scleroderma	4.8e-05	0.000387	CcSEcCtD
Aciclovir—Decreased appetite—Methotrexate—systemic scleroderma	4.74e-05	0.000382	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Methotrexate—systemic scleroderma	4.71e-05	0.00038	CcSEcCtD
Aciclovir—Fatigue—Methotrexate—systemic scleroderma	4.7e-05	0.000379	CcSEcCtD
Aciclovir—Asthenia—Prednisone—systemic scleroderma	4.68e-05	0.000377	CcSEcCtD
Aciclovir—Pain—Methotrexate—systemic scleroderma	4.66e-05	0.000376	CcSEcCtD
Aciclovir—Pruritus—Prednisone—systemic scleroderma	4.62e-05	0.000372	CcSEcCtD
Aciclovir—Feeling abnormal—Methotrexate—systemic scleroderma	4.49e-05	0.000362	CcSEcCtD
Aciclovir—Diarrhoea—Prednisone—systemic scleroderma	4.46e-05	0.00036	CcSEcCtD
Aciclovir—Gastrointestinal pain—Methotrexate—systemic scleroderma	4.46e-05	0.00036	CcSEcCtD
Aciclovir—Urticaria—Methotrexate—systemic scleroderma	4.33e-05	0.000349	CcSEcCtD
Aciclovir—Dizziness—Prednisone—systemic scleroderma	4.31e-05	0.000348	CcSEcCtD
Aciclovir—Abdominal pain—Methotrexate—systemic scleroderma	4.31e-05	0.000348	CcSEcCtD
Aciclovir—Body temperature increased—Methotrexate—systemic scleroderma	4.31e-05	0.000348	CcSEcCtD
Aciclovir—Vomiting—Prednisone—systemic scleroderma	4.15e-05	0.000335	CcSEcCtD
Aciclovir—Rash—Prednisone—systemic scleroderma	4.11e-05	0.000332	CcSEcCtD
Aciclovir—Dermatitis—Prednisone—systemic scleroderma	4.11e-05	0.000331	CcSEcCtD
Aciclovir—Headache—Prednisone—systemic scleroderma	4.09e-05	0.00033	CcSEcCtD
Aciclovir—Hypersensitivity—Methotrexate—systemic scleroderma	4.02e-05	0.000324	CcSEcCtD
Aciclovir—Asthenia—Methotrexate—systemic scleroderma	3.91e-05	0.000315	CcSEcCtD
Aciclovir—Nausea—Prednisone—systemic scleroderma	3.88e-05	0.000313	CcSEcCtD
Aciclovir—Pruritus—Methotrexate—systemic scleroderma	3.86e-05	0.000311	CcSEcCtD
Aciclovir—Diarrhoea—Methotrexate—systemic scleroderma	3.73e-05	0.000301	CcSEcCtD
Aciclovir—Dizziness—Methotrexate—systemic scleroderma	3.61e-05	0.000291	CcSEcCtD
Aciclovir—Vomiting—Methotrexate—systemic scleroderma	3.47e-05	0.00028	CcSEcCtD
Aciclovir—Rash—Methotrexate—systemic scleroderma	3.44e-05	0.000277	CcSEcCtD
Aciclovir—Dermatitis—Methotrexate—systemic scleroderma	3.43e-05	0.000277	CcSEcCtD
Aciclovir—Headache—Methotrexate—systemic scleroderma	3.42e-05	0.000275	CcSEcCtD
Aciclovir—Nausea—Methotrexate—systemic scleroderma	3.24e-05	0.000261	CcSEcCtD
